BioVaxys Technology Corp.
BVAXF
$0.0332
$0.00113.43%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -296.27% | -12.90% | 59.08% | 63.65% | 154.10% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.07% | 26.32% | -40.62% | -98.89% | -1,126.66% |
| Change in Net Operating Assets | -20.79% | -88.39% | -174.28% | 145.53% | -38.47% |
| Cash from Operations | -34,994.44% | -49,480.00% | -1,591.01% | 38.73% | 100.76% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.01% | -- | -- | 7.67% | 289.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -16.40% | -- | -- | 2.49% | 288.98% |
| Foreign Exchange rate Adjustments | -785.71% | 31.58% | 96.88% | 100.00% | -600.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.36% | -51,200.00% | 1,251.43% | -1,766.35% | 1,470.63% |